← Back to Clinical Trials
Recruiting NCT07585409

NCT07585409 Physical Activity in Persons With Parkinson's Disease

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07585409
Status Recruiting
Phase
Sponsor Karolinska Institutet
Condition PARKINSON DISEASE (Disorder)
Study Type OBSERVATIONAL
Enrollment 450 participants
Start Date 2026-01-15
Primary Completion 2030-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 450 participants in total. It began in 2026-01-15 with a primary completion date of 2030-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This project aims to identify why some people with Parkinson's disease (PwPD) become less physically active, and which factors support or hinder activity. Understanding these factors is essential for developing person centred interventions and effective support that can be implemented in routine healthcare. A national, multicentre longitudinal cohort study will be conducted including approx 450 PwPD from five Swedish regions (including the internal pilot NCT06901869). Physical activity will be measured objectively with activity monitors, combined with clinical assessments and digital questionnaires over four years. The primary outcome is physical activity level (accelerometer measured decline), and exposure variables include physical, cognitive, disease specific, social, environmental, motivational, and personal factors. Data collection involves clinical tests, questionnaires, accelerometer data, and patient reported experiences. This is a continuation of an internal pilot study NCT06901869. The study will enable early identification of those at risk for declining activity and guide development of person centred, evidence based interventions. Long term, it aims to integrate activity monitoring and risk factor screening into routine care to improve health and quality of life for PwPD.

Eligibility Criteria

Inclusion Criteria: * People diagnosed with idiopathic Parkinson's disease * Hoehn \& Yahr 1 to 4 Exclusion Criteria: * Hoehn \& Yahr 5 (i.e. wheelchair bound or bedridden unless aided) * Unable to perform critical physical activity and clinical assessments

Contact & Investigator

Central Contact

Compliance Office Karolinska Insitutet

✉ compliance@ki.se

📞 +46852480000

Principal Investigator

Erika Franzén

PRINCIPAL INVESTIGATOR

Karolinska Institutet

Frequently Asked Questions

Who can join the NCT07585409 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying PARKINSON DISEASE (Disorder). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07585409 currently recruiting?

Yes, NCT07585409 is actively recruiting participants. Contact the research team at compliance@ki.se for enrollment information.

Where is the NCT07585409 trial being conducted?

This trial is being conducted at Stockholm, Sweden.

Who is sponsoring the NCT07585409 clinical trial?

NCT07585409 is sponsored by Karolinska Institutet. The principal investigator is Erika Franzén at Karolinska Institutet. The trial plans to enroll 450 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology